SGO1-AS1: A Potential Drug Target and Biomarker (G100874028)

Target Name: SGO1-AS1

NCBI ID: G100874028

SGO1-AS1

Other Name(s): SGOL1-AS1 | SGOL1 antisense RNA 1 | SGO1 antisense RNA 1

SGO1-AS1: A Potential Drug Target and Biomarker

SGO1-AS1, also known as SGO1 or sonic hedgehog gene 1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of certain diseases.

SGO1-AS1 is a member of the hedgehog gene family, which is known for its role in the development and progression of various diseases, including cancer. The hedgehog gene family has been implicated in the development of cancer due to its involvement in cell signaling pathways, which have been linked to cancer growth and progression.

SGO1-AS1 is expressed in various tissues and cells throughout the body, including tissues of the nervous system, eye, and skin. Its expression has also been detected in various cancer types, including lung, breast, and ovarian cancer. This suggests that SGO1-AS1 may be a potential biomarker for cancer, and that its levels may be affected by the development and progression of these diseases.

In addition to its potential as a drug target, SGO1-AS1 has also been identified as a potential biomarker for several diseases. For example, studies have shown that SGO1-AS1 levels are elevated in individuals with certain skin conditions, such as eczema and psoriasis. This suggests that SGO1-AS1 may be a potential biomarker for these conditions.

SGO1-AS1 has also been shown to be involved in several important biological processes in the body, including cell signaling, tissue repair, and inflammation. Its expression has been linked to the development and progression of various diseases, including cancer, and its levels have been shown to be affected by a variety of factors, including environmental toxins, such as pollution and radiation.

The potential drug target for SGO1-AS1 is its role in cell signaling pathways. SGO1-AS1 has been shown to be involved in several signaling pathways that are important for cell growth, survival, and reproduction. For example, SGO1-AS1 has been shown to be involved in the Wnt signaling pathway, a pathway that is important for the development and growth of tissues in the body.

In addition to its involvement in the Wnt pathway, SGO1-AS1 has also been shown to be involved in several other signaling pathways that are important for cell signaling. For example, SGO1-AS1 has been shown to be involved in the Notch signaling pathway, a pathway that is important for the development and regulation of tissues in the body.

The potential drug target for SGO1-AS1 is its role in cell signaling pathways. Its unique structure and function make it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of various diseases. Further research is needed to fully understand the role of SGO1-AS1 in cell signaling pathways and its potential as a drug.

Protein Name: SGO1 Antisense RNA 1

The "SGO1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SGO1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets